Home › Employers › Sante Clinical Research LLC
Sante Clinical Research LLC: H-1B salaries and sponsorship
Sante Clinical Research LLC filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 2. Median offered salary: $68,713.
Does Sante Clinical Research LLC sponsor H-1B visas?
Sante Clinical Research LLC filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on May 11, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Clinical Research Coordinator | 4 | $68,713 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2025 | 1 | $67,829 |
| FY2026 | 3 | $69,597 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Clinical Research Coordinator | $69,597–$69,600 Level I | Kerrville, TX | May 11, 2026 | Oct 1, 2026 | Certified |
| Clinical Research Coordinator | $69,597–$69,600 Level I | Kerrville, TX | May 8, 2026 | Oct 1, 2026 | Denied |
| Clinical Research Coordinator | $69,597–$69,600 Level I | Kerrville, TX | May 7, 2026 | Oct 1, 2026 | Denied |
| Clinical Research Coordinator | $67,829–$68,640 Level I | Kerrville, TX | Mar 17, 2025 | Mar 18, 2025 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).